R etinopathy of prematurity (ROP) is a proliferative retinal vascular disease that affects approximately two-thirds of premature infants weighing fewer than 1250 g at birth. Most cases of ROP are mild and resolve without intervention within several months. However, 5% to 10% of cases progress to severe ROP, which can lead to retinal detachment and permanent blindness if untreated. A major challenge is that clinical ROP diagnosis is based solely on the appearance of retinal vessels on dilated ophthalmoscopic examination at the neonatal intensive care unit bedside, which is highly subjective and qualitative. The most critical feature of severe, treatmentrequiring ROP is the presence of plus disease, which was defined during the 1980s by an international consensus panel as arterial tortuosity and venous dilation of the posterior retinal vessels that is greater than or equal to that found in a standard published retinal photograph. 1, 2 In 2005, a revised international consensus panel established a 3-tier grading classification of plus disease (ie, normal, pre-plus disease, and plus disease) to capture an intermediate level of severity as an additional prognostic indicator. [3] [4] [5] Several major studies funded by the National Institutes of Health 1, 4 and several other clinical trials 6 have shown that severe ROP (characterized by plus disease) may be effectively treated with laser photocoagulation 1, 4 or with intravitreal injection of pharmacological agents, such as bevacizumab. 6 Therefore, it is essential to diagnose plus disease in an accurate and timely manner.
Retinopathy of prematurity remains a leading cause of childhood blindness worldwide. There are several challenges to delivery of care: (1) clinical diagnosis is highly variable, and high interobserver inconsistency on plus disease diagnosis, even among ROP experts, has been well-documented 7, 8 ; (2) the number of ophthalmologists and neonatologists willing and able to manage ROP is insufficient because of logistical difficulties, the extensive training process, time-consuming examination, and significant malpractice liability [9] [10] [11] [12] ; and (3) the incidence of ROP worldwide is rising because of advances in neonatology. 13 These challenges have stimulated research in developing quantitative and objective approaches to ROP diagnosis using computer-based image analysis (CBIA). [14] [15] [16] [17] [18] Although multiple groups have developed CBIA systems for plus disease diagnosis in ROP, no automated systems have demonstrated diagnostic performance equivalent to practicing clinicians. 14 A fully automated, validated CBIA system would improve quality of care by providing diagnostic assistance to clinicians and could improve accessibility of care by creating potential for large-scale automated screening systems. Deep learning (DL) has become the state-of-the-art solution in a wide range of CBIA problems. 19 Convolutional neural networks (CNNs) have been successfully used for automated diagnosis of skin cancer, 20 
Data Sets
Training, validation, and test data sets were created from a database of almost 6000 deidentified posterior retinal images obtained using a commercially available camera (RetCam; Natus Medical Incorporated) as part of the multicenter Imaging and Informatics in Retinopathy of Prematurity (i-ROP) cohort study. A standard imaging protocol was used by all 8 study centers, and the images were obtained between July 2011 and December 2016. Although images were obtained in 5 standard fields of view (ie, posterior, nasal, temporal, superior, and inferior), only posterior images were used in this analysis.
Image Grading
A reference standard diagnosis (RSD) was assigned to each image using previously published methods 31 based on independent image-based diagnoses by 3 trained graders (2 ophthalmologists and 1 study coordinator) and the clinical diagnosis (obtained by full evaluation, including dilated ophthalmoscopic examination) by an expert ophthalmologist. Images
Key Points
Question Can an algorithm based on deep learning achieve expert-level performance at diagnosing plus disease in retinopathy of prematurity?
Finding In this technology evaluation study including 5511 retinal photographs, using 5-fold cross-validation, the algorithm achieved mean areas under the receiver operating characteristic curve of 0.94 and 0.99 for the diagnoses of normal and plus disease, respectively. On an independent test set of 100 images, the algorithm achieved 91% accuracy and a quadratic-weighted κ coefficient of 0.92, outperforming 6 of 8 retinopathy of prematurity experts. 
Meaning

Algorithm Development
The algorithm used 2 neural network architectures, which are complex functions designed to receive images as input (ie, a grid of pixel intensity values), and were trained to produce some desired output. This training process involved presenting the network with corresponding RSDs, which were used to adjust the network's numerous internal parameters to output the correct diagnoses. Both networks used by our algorithm were CNNs, which are highly specialized for image data. Convolutional neural networks operate by learning and applying a series of filters that emphasize image features that are relevant to the task at hand. The first of the CNNs used by our algorithm was a vessel segmentation network, which was trained to output a new image with pixel intensities ranging between 0 and 1. Each pixel value represents the probability that it belongs to a retinal vessel. This process effectively eliminates variations in pigmentation, illumination, and nonvascular pathology, which are commonly observed in images from patients with ROP. In this work, we used the U-Net architecture 32 (eMethods 1 in the Supplement). The second CNN was trained to diagnose plus disease from the preprocessed images. Through a series of alternating filtering and down sampling operations, a classification network reduced images to a set of features, which were transformed into 3 values representing the probability of that image corresponding to normal, pre-plus disease, or plus disease. We used the Inception version 1 architecture by Szegedy et al, 33 which was pretrained on the ImageNet database of 1.2 million images from 1000 classes. 34 This process of transfer learning has been shown to improve classification performance because of the network having learned highly generalizable image features from an unrelated but large and highly diverse data set of images (eMethods 2 in the Supplement).
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Evaluation
The data set was subdivided into 5 near-equal parts and used to train 5 separate classification CNNs (ie, 5-fold crossvalidation). The data were divided to ensure that images acquired from the same patient (eg, left and right eyes or from multiple sessions) were not split across training and validation data. A detailed breakdown of the training and validation sets is provided in the Table. Each CNN was trained on 4 splits (80%) and tested on the remaining split (20%) to assess the algorithm's ability to generalize to previously unseen images from different patients. The cross-validated CNNs were evaluated using receiver operator characteristic (ROC) curves. Areas under the ROC curve were used to determine the binary outcomes of normal (vs pre-plus disease/ plus disease) and plus disease (vs normal/pre-plus disease) compared with the RSD.
Performance of the best model (based on crossvalidation) for plus disease diagnosis was further evaluated against 8 international ROP experts on an independent test set of 100 images, described previously with 54 normal, 31 preplus disease, and 15 plus disease images. 8, 36 These images were not included in any of the training or validation sets. Each participating expert had more than 10 years of clinical experience in ROP care and had published more than 5 peerreviewed articles on ROP. Five of 8 experts served as principal investigators for the multicenter Early Treatment for ROP study. 2, 4 Interexpert agreement was assessed using quadraticweighted κ coefficients and interpreted using a commonly accepted scale: 0 to 0.20 indicated slight agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, substantial agreement; and 0.81 to 1.0, near-perfect agreement. 37 κ Scores for agreement between the bestperforming CNN from cross-validation were calculated for all experts, the 8 expert consensus (mode) diagnosis (there were no ties), and the RSD.
Interpretation of Learned Features
Following training, image features learned by the classification network were extracted for all images in the training set as a high-dimensional vector. Feature vectors were visualized in 2 dimensions using t-distributed stochastic neighbor embedding (t-SNE), a dimensionality reduction technique that attempts to minimize distances between similar features while maximizing distances between dissimilar features. 38 This t-SNE embedding was visualized as a 2-dimensional scatter plot, with each point corresponding to an image in feature space (eMethods 3 in the Supplement). Figure 2 summarizes diagnostic performance of the bestperforming model from cross-validation (split 3; Figure 1 ) on 100 images, with diagnoses from 8 international ROP experts. Sensitivity and specificity of the DL algorithm for detecting plus disease were 93% and 94%, respectively. For detection of pre-plus disease or worse, the sensitivity and specificity were 100% and 94%, respectively. As shown in Figure 2A , the DL algorithm diagnosed 91 of 100 images (91.0%) correctly, whereas 8 experts had an average accuracy of 82.0% (range, 77-94). 
Results
Automated Diagnosis of Plus Disease Using Deep Learning
Comparison With Expert Diagnosis
Interpretation of Learned Features
The t-SNE was used to visualize high-dimensional features learned by the DL algorithm in 2 dimensions ( Figure 3) . Each point on the scatter plot corresponds to an individual retinal image, where similar images (based on their features) appear nearer to one another than dissimilar images. The colored RSD labels are used only for visualization to denote the different clusters. The t-SNE demonstrates qualitative separation among different disease grades. Normal and plus disease form 2 distinct clusters with pre-plus disease bridging them, demonstrating a continuum of disease severity.
Discussion
This study presents the results of a DL-based algorithm trained to diagnose plus disease automatically using retinal images from premature infants at risk of ROP. The key findings are (1) this fully automated CBIA system can diagnose plus disease with comparable or better proficiency than ROP experts, and (2) analysis of features using DL provides insight about the diagnostic process used by experts. Evidence-based ROP management guidelines are based on treatment for presence of plus disease to prevent visual loss and blindness, 1,2 yet inconsistency in plus disease diagnosis leads to clinically significant differences in management. 39 
Research Original Investigation Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks
Saturation Targeting-II trials 39 found variation in diagnosis of treatment-requiring ROP among international experts due to differences in plus disease diagnosis. Objective assessment of disease severity, such as with our CNN-based image analysis system, has potential to improve clinical outcomes. The i-ROP DL algorithm outperformed not only most experts in this study ( Figure 2B ) but also all prior CBIA systems in ROP. 14 We have previously published results from a different system using machine learning methods rather than CNN-based methods, 42,43 which was able to accurately diagnose pre-plus disease and plus disease but only by using manually segmented images in which retinal vessels were traced by hand and input into the system. Other systems are semiautomated (ie, require manual identification of the optic disc and a few key vessel segments) but have only weakly correlated with 2-level diagnosis (not plus disease vs plus disease). 14, 16 In contrast, our current system performed almost perfectly and performed better than most experts on the test set of 100 images at 3-level diagnosis (normal vs pre-plus disease vs plus disease) using raw image files without the need for manual segmentation. We also observed that each of the experts' operating points for sensitivity and specificity of diagnosis of plus disease fell on or near the ROC curve for the DL algorithm ( Figure 2C ), suggesting that the diagnosis of individual experts may be predicted by tuning the operating point and/or slightly retraining the CNN to better understand that expert's unique biases.
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Interpretation of DL outputs may facilitate better understanding of the cognitive processes used to make diagnoses in image-based diagnostic specialties, such as ophthalmology, dermatology, pathology, and radiology. 20, 26, 45 In ROP, studies have demonstrated that experts deviate from the published and internationally accepted definition of plus disease in several ways 42 and that experts explain their diagnoses using terms such as "experience" and "clinical judgment." 42, 43, 46 In the same way, neural networks are often regarded as black boxes, since the features used by the multiple layers of the model are not readily interpretable. The t-SNE visualization (Figure 3 ) of image features learned by the algorithm supports the concept of a phenotypic continuum of disease severity, which has been proposed as an explanation for interobserver differences between disease categories. 8, 36 This is a particularly interesting finding because the CNN was trained with the categorical labels "normal," "pre-plus disease," and "plus disease" without intrinsic ordering as part of the RSD. In other words, the system learned that normal, pre-plus disease, and plus disease categories reflect a continuum, and our results demonstrate that expert behavior is predictable based on knowing where along that continuum each expert distinguishes between those categories (Figure 1 ). Further analysis of the CNN using saliency and class activation maps may reveal features and locations that are informative of ROP pathophysiology, potentially serving as an educational tool for clinicians. For several reasons, modeling a continuous phenotype using a DL-derived continuous score rather than discrete categories (eg, normal, pre-plus disease, and plus disease) may improve clinical care in ROP. First, a continuous score provides more granularity for determining relative disease progression or regression, which may be lost within subjective 2-level or 3-level disease categories because individual eyes may measurably worsen, remain the same, or improve over time. Additionally, physicians are accustomed to incorporating continuous biomarkers (eg, blood pressure) into clinical decision-making. A plus disease score in the upper range may or may not lead to treatment for ROP but could also be put into context of other known risk factors, pace and progression of disease over time, clinical judgment, and published validation studies. Finally, DL-based objective disease metrics may be incorporated into screening strategies to automatically identify clinically relevant disease and initiate appropriate referral. Incorporating DL-based screening into fundus camera systems and telemedicine platforms for ROP and other image-based diseases may improve the objectivity, accuracy, and efficiency of health care delivery.
Limitations
This study has several limitations. Convolutional neural networks are only as robust as the data on which they are trained. In this case, we used nearly 6000 images from 8 different institutions, each with a rigorous RSD, which was itself a consensus diagnosis of 4 separate diagnoses (image-based diagnosis by 3 experts and ophthalmoscopic diagnosis by 1 expert), which should improve the external validity of our system. It is unknown how factors such as image quality, resolution, different camera systems, and field of view may affect the output of the i-ROP DL system. 47 These topics warrant further study. Image preprocessing methods are specific for each data set and CNN, representing a critical step in image classification tasks that eliminates variations, which may introduce bias during model training. In our data set, such variations included differences in retinal pigmentation, brightness, contrast, and textual annotations. Other preprocessing and postprocessing methods, such as binarization and morphological operations, may improve generalizability of our algorithm and could be the subject of future analyses. Our system currently only classifies plus disease, one component of the International Classification of Retinopathy of Prematurity system. 3 Ideally, a fully automated ROP screening platform could classify zone, stage, and overall disease category as well as predict need for treatment. These are the topics of ongoing study.
Conclusions
These results demonstrate that the incorporation of deep neural networks may enable automated screening and diagnosis for ROP with high accuracy and repeatability. These results may change the way ROP is diagnosed in the future and are broadly relevant to other medical fields that rely primarily on subjective image-based diagnostic features. Future work will involve comparison of features learned by the DL algorithm with known morphological features, evaluation of deep neural networks for other components of the ROP clinical examination, and application to other retinal diseases. Incorporation of this technology into fundus cameras or telemedicine systems could provide advice at the point of care and has the potential to improve the quality, accessibility, and cost of ROP screening worldwide. This visualization demonstrates that the convolutional neural network is able to automatically generate features that roughly separate the 3 diagnoses and that they appear to run along a continuum of disease severity. 
